aTyr Pharma

Yahoo Finance • 12 hours ago

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in aTyr between January 16, 2... Full story

Yahoo Finance • 14 hours ago

aTyr Pharma, Inc. (ATYR) Securities Class Action Deadline Alert: Shamis & Gentile, P.A. Alerts Investors of Important Lead Plaintiff Deadline of December 8, 2025

MIAMI, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Shamis & Gentile, P.A. alerts investors that a securities class action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) on behalf of investors who purchased or other... Full story

Yahoo Finance • yesterday

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of aTyr Pharma, Inc. Common Stock and Sets a Lead Plaintiff Deadline of December 8, 2025

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock of aTyr Pharma, Inc. (“aTyr” or the “Company”) (N... Full story

Yahoo Finance • 2 days ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

SAN FRANCISCO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that its late-stage study of efzofitimod for t... Full story

Yahoo Finance • 7 days ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower – Hagens Berman

SAN FRANCISCO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that its late-stage study of efzofitimod for t... Full story

Yahoo Finance • 11 days ago

aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society (ERS) Congress 2025

Clinical benefit for efzofitimod across multiple disease-related health outcomes reported. Improvement in Fatigue Assessment Scale Total Score at week 48 observed in the 5.0 mg/kg efzofitimod treatment group vs placebo (p=0.0226). Improv... Full story

Yahoo Finance • 16 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of aTyr Pharma, Inc. - ATYR

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR).  Such investors are advised to contact Danielle Peyton at newaction... Full story

Yahoo Finance • 19 days ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

SAN FRANCISCO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that its late-stage study of efzofitimod for... Full story

Yahoo Finance • 22 days ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT™ Study Failure Drives Shares 80% Lower -- Hagens Berman

SAN FRANCISCO, Sept. 18, 2025 (GLOBE NEWSWIRE) -- On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that its late-stage study of efzofitimod for... Full story

Yahoo Finance • 25 days ago

INVESTOR ALERT: Investigation of aTyr Pharma, Inc. (ATYR) Announced by Holzer & Holzer, LLC

ATLANTA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) complied with federal securities laws. On September 15, 2025, aTyr announced topline res... Full story

Yahoo Finance • 25 days ago

Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Tuesday; aTyr Pharma, Oracle to Advance

The most-talked-about stocks in the Reddit subforum Wallstreetbets were mostly higher hours before T PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 25 days ago

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks fell late Monday afternoon with the NYSE Health Care Index and the Health Care Se PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 26 days ago

Which stocks are most active on Monday?

Curious about the most active stocks on Monday? Find out which stocks are dominating the market action! [mostactive] TODAY'S MOST ACTIVE STOCKS TICKER CHANGE COMMENT ATCH [https://www.chartmill.com/stock/quote/ATCH/profile]... Full story

Yahoo Finance • 26 days ago

BREAKING: aTyr Pharma Shares Plummet 80%; Investors Should Contact Block & Leviton to Potentially Recover Losses

BOSTON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating aTyr Pharma, Inc. (Nasdaq: ATYR) for potential securities law violations. Investors who have lost money in their aTyr Pharma, Inc. investment should contact the... Full story

Yahoo Finance • 26 days ago

aTyr Pharma stock tanks after missing main goal in lung disease study

[Holding paper lungs in the hand, lung cancer, covid-19 virus, world tuberculois day, no tabacco day, organ donation, air pollution concept] BeritK/iStock via Getty Images aTyr Pharma (NASDAQ:ATYR [https://seekingalpha.com/symbol/ATYR]) s... Full story

Yahoo Finance • 26 days ago

Sector Update: Health Care Stocks Advance Premarket Monday

Health care stocks were advancing premarket Monday, with the iShares Biotechnology ETF (IBB) advanci PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 26 days ago

aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis

Study did not meet primary endpoint in change from baseline in mean daily oral corticosteroid (OCS) dose at week 48, although clinical benefit for efzofitimod observed across multiple study parameters. 52.6% of patients treated with 5.0 m... Full story

Yahoo Finance • 28 days ago

Noteworthy Friday Option Activity: TKO, ATYR, GME

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in TKO Group Holdings Inc (Symbol: TKO), where a total volume of 27,876 contracts has been traded thus far today, a contract... Full story

Yahoo Finance • last month

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tR... Full story

Yahoo Finance • last month

Catalyst Watch: Apple event, Oracle earnings, and Klarna leads an IPO blitz

[View of New York City] simonkr/E+ via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. SUNDA... Full story